Literature DB >> 20212039

Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis.

Guillermo Romero1, W Bruce Sneddon, Yanmei Yang, David Wheeler, Harry C Blair, Peter A Friedman.   

Abstract

Bone growth and remodeling depend upon the opposing rates of bone formation and resorption. These functions are regulated by intrinsic seven transmembrane-spanning receptors, the parathyroid hormone receptor (PTH1R) and frizzled (FZD), through their respective ligands, parathyroid hormone (PTH) and Wnt. FZD activation of canonical beta-catenin signaling requires the adapter protein Dishevelled (Dvl). We identified a Dvl-binding motif in the PTH1R. Here, we report that the PTH1R activates the beta-catenin pathway by directly recruiting Dvl, independent of Wnt or LRP5/6. PTH1R coimmunoprecipitated with Dvl. Deleting the carboxyl-terminal PTH1R PDZ-recognition domain did not abrogate PTH1R-Dvl interactions; nor did truncating the receptor at position 480. However, further deletion eliminating the putative Dvl recognition domain abolished PTH1R interactions with Dvl. PTH activated beta-catenin in a time- and concentration-dependent manner and translocated beta-catenin to the nucleus. beta-Catenin activation was inhibited by Dvl2 dominant negatives and by short hairpin RNA sequences targeted against Dvl2. PTH-induced osteoclastogenesis was also inhibited by Dvl2 dominant negative mutants. These findings demonstrate that G protein-coupled receptors other than FZD directly activate beta-catenin signaling, thereby mimicking many of the functions of the canonical Wnt-FZD pathway. The distinct modes whereby FZD and PTH1R activate beta-catenin control convergent or divergent effects on osteoblast differentiation, and osteoclastogenesis may arise from PTH1R-induced second messenger phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20212039      PMCID: PMC2863183          DOI: 10.1074/jbc.M110.102970

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  beta-Arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins.

Authors:  W Chen; L A Hu; M V Semenov; S Yanagawa; A Kikuchi; R J Lefkowitz; W E Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

Review 2.  Frizzleds: new members of the superfamily of G-protein-coupled receptors.

Authors:  Craig C Malbon
Journal:  Front Biosci       Date:  2004-05-01

3.  Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth.

Authors:  Syed Haq; Ashour Michael; Michele Andreucci; Kausik Bhattacharya; Paolo Dotto; Brian Walters; James Woodgett; Heiko Kilter; Thomas Force
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-31       Impact factor: 11.205

4.  Interaction between the internal motif KTXXXI of Idax and mDvl PDZ domain.

Authors:  Timothy B C London; Ho-Jin Lee; Youming Shao; Jie Zheng
Journal:  Biochem Biophys Res Commun       Date:  2004-09-10       Impact factor: 3.575

Review 5.  Wnt signaling in osteoblasts and bone diseases.

Authors:  Jennifer J Westendorf; Rachel A Kahler; Tania M Schroeder
Journal:  Gene       Date:  2004-10-27       Impact factor: 3.688

6.  Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled.

Authors:  Hing-C Wong; Audrey Bourdelas; Anke Krauss; Ho-Jin Lee; Youming Shao; Dianqing Wu; Marek Mlodzik; De-Li Shi; Jie Zheng
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

7.  Dual role of PKA in phenotypic modulation of vascular smooth muscle cells by extracellular ATP.

Authors:  D Kyle Hogarth; Nathan Sandbo; Sebastien Taurin; Vladimir Kolenko; Joseph M Miano; Nickolai O Dulin
Journal:  Am J Physiol Cell Physiol       Date:  2004-04-14       Impact factor: 4.249

8.  Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50).

Authors:  W Bruce Sneddon; Colin A Syme; Alessandro Bisello; Clara E Magyar; Moulay Driss Rochdi; Jean-Luc Parent; Edward J Weinman; Abdul B Abou-Samra; Peter A Friedman
Journal:  J Biol Chem       Date:  2003-08-14       Impact factor: 5.157

9.  Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein.

Authors:  Qiang Fu; Robert L Jilka; Stavros C Manolagas; Charles A O'Brien
Journal:  J Biol Chem       Date:  2002-10-02       Impact factor: 5.157

10.  Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.

Authors:  Wei Yao; Zhiqiang Cheng; Mohammad Shahnazari; Wewei Dai; Mark L Johnson; Nancy E Lane
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

View more
  40 in total

1.  Role of PTH1R internalization in osteoblasts and bone mass using a phosphorylation-deficient knock-in mouse model.

Authors:  Nabanita S Datta; Tareq A Samra; Chandrika D Mahalingam; Tanuka Datta; Abdul B Abou-Samra
Journal:  J Endocrinol       Date:  2010-10-07       Impact factor: 4.286

2.  Effects of age on parathyroid hormone signaling in human marrow stromal cells.

Authors:  Shuanhu Zhou; Ericka M Bueno; Sung Won Kim; Ilaria Amato; Longxiang Shen; Jochen Hahne; Ilan Bleiberg; Paul Morley; Julie Glowacki
Journal:  Aging Cell       Date:  2011-05-25       Impact factor: 9.304

3.  Reprogramming adult dermis to a neonatal state through epidermal activation of β-catenin.

Authors:  Charlotte A Collins; Kai Kretzschmar; Fiona M Watt
Journal:  Development       Date:  2011-10-26       Impact factor: 6.868

4.  β-Arrestin and dishevelled coordinate biased signaling.

Authors:  Gunnar Schulte; Sudha K Shenoy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

Review 5.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

6.  Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.

Authors:  Yanmei Yang; Bin Wang
Journal:  Biochem Biophys Res Commun       Date:  2015-06-03       Impact factor: 3.575

7.  The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway.

Authors:  Yanmei Yang; Harry C Blair; Irving M Shapiro; Bin Wang
Journal:  J Biol Chem       Date:  2015-05-15       Impact factor: 5.157

Review 8.  Role of fibroblast growth factor 2 and Wnt signaling in anabolic effects of parathyroid hormone on bone formation.

Authors:  Yurong Fei; Marja M Hurley
Journal:  J Cell Physiol       Date:  2012-11       Impact factor: 6.384

9.  Parathyroid hormone-related protein activates Wnt signaling to specify the embryonic mammary mesenchyme.

Authors:  Minoti Hiremath; Pamela Dann; Jennifer Fischer; Daniela Butterworth; Kata Boras-Granic; Julie Hens; Joshua Van Houten; Wei Shi; John Wysolmerski
Journal:  Development       Date:  2012-10-03       Impact factor: 6.868

10.  Defective postnatal endochondral bone development by chondrocyte-specific targeted expression of parathyroid hormone type 2 receptor.

Authors:  Dibyendu Kumar Panda; David Goltzman; Andrew C Karaplis
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-23       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.